Literature DB >> 18077142

Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males.

Fleur Zijlstra1, Jan Booij, Wim van den Brink, Ingmar H A Franken.   

Abstract

Opiate addiction is a chronic disorder characterized by relapse behaviour, often preceded by craving and anhedonia. Chronic craving and anhedonia have been associated with low availability of dopamine D2 receptors (D2Rs) and cue-elicited craving has been linked with endogenous dopamine release. We studied D2R availability and cue-elicited endogenous dopamine release in 12 abstinent opiate-dependent males and 18 age-matched male controls with [123I]IBZM SPECT. Craving was manipulated with a video containing heroin-related stimuli. Moreover, chronic craving, anhedonia and cue-elicited craving were measured. We found lower baseline D2R availability in opiate-dependent subjects than controls in the left caudate nucleus. D2R availability in the putamen correlated negatively with years of opiate use. Opiate-dependent subjects demonstrated higher dopamine release after cue-exposure in the right putamen than controls. Chronic craving and anhedonia were positively correlated with DA release. Treatment strategies that increase D2Rs may, therefore, be an interesting approach to prevent relapse in opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18077142     DOI: 10.1016/j.euroneuro.2007.11.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  40 in total

1.  Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

Authors:  Bw Downs; M Oscar-Berman; Rl Waite; Ma Madigan; J Giordano; T Beley; S Jones; T Simpatico; M Hauser; J Borsten; F Marcelo; Er Braverman; R Lohmann; K Dushaj; M Helman; D Barh; St Schoenthaler; D Han; K Blum
Journal:  J Genet Syndr Gene Ther       Date:  2013-06-03

2.  Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.

Authors:  Diana Martinez; Phillip A Saccone; Fei Liu; Mark Slifstein; Daria Orlowska; Alex Grassetti; Stephanie Cook; Allegra Broft; Ronald Van Heertum; Sandra D Comer
Journal:  Biol Psychiatry       Date:  2011-10-19       Impact factor: 13.382

3.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

Review 4.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

Review 5.  Natural rewards, neuroplasticity, and non-drug addictions.

Authors:  Christopher M Olsen
Journal:  Neuropharmacology       Date:  2011-04-01       Impact factor: 5.250

Review 6.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 7.  Neuromodulation for Addiction by Transcranial Direct Current Stimulation: Opportunities and Challenges.

Authors:  Shahid Bashir; Woo-Kyoung Yoo
Journal:  Ann Neurosci       Date:  2016-10-04

8.  Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.

Authors:  Felicia Kamp; Lisa Proebstl; Nora Penzel; Kristina Adorjan; Andrej Ilankovic; Oliver Pogarell; Gabi Koller; Michael Soyka; Peter Falkai; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2018-08-27       Impact factor: 7.853

9.  Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

Authors:  Francesco Leri; Yan Zhou; Benjamin Goddard; AnneMarie Levy; Derek Jacklin; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-06       Impact factor: 4.600

10.  Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.

Authors:  Ying Liu; Mei Han; Xingdang Liu; Yanping Deng; Yu Li; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Jinlong Gao
Journal:  Psychopharmacology (Berl)       Date:  2013-05-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.